Hansoh s HS-20093 builds on GSK s oncology portfolio of clinical-stage antibody-drug conjugates, following earlier agreement for Hansoh s HS-20089 focused on gynaecologic cancers .
- Hansoh s HS-20093 builds on GSK s oncology portfolio of clinical-stage antibody-drug conjugates, following earlier agreement for Hansoh s HS-20089 focused on gynaecologic cancers
- HS-20093 has.
Drugs, EU approves dostarlimab in first line with chemo for endometrial cancer ruetir.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ruetir.com Daily Mail and Mail on Sunday newspapers.